MIRA INFORM REPORT

 

 

Report Date :

27.10.2007

 

IDENTIFICATION DETAILS

 

Name :

HARIKA DRUGS PRIVATE LIMITED

 

 

Registered Office :

36/A, Vengal Rao Nagar, S. R. Nagar,  Hyderabad – 500038, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

19.09.1989

 

 

Com. Reg. No.:

01-10584

 

 

CIN No.:

[Company Identification No.]

U24230AP1989PTC010584

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDH00713G / HYDH00714A

 

 

PAN No.:

[Permanent Account No.]

AAACH4986P

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Bulk Drugs

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 120000

 

 

Status :

Good

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established company having satisfactory track. Directors are reported as experienced, respectable and resourceful businessmen. Their trade relations are fair. Financial position is good. Payments are correct and as per commitments.

 

The company can be considered good for your proposed business dealings at usual trade terms and conditions.

 

 

LOCATIONS

 

Registered Office :

36/A, Vengal Rao Nagar, S. R. Nagar,  Hyderabad – 500038, Andhra Pradesh, India

Tel. No.:

91-40-23814863 / 23700915

Fax No.:

91-40-23700731

E-Mail :

Hyd1_amarbabu@sancharnet.in

bnandcompany@yahoo.com

Area :

3000 sq. fts. (Owned)

 

 

Factory 1 :

Located at: Medak, Andhra Pradesh

Tel. No.:

91-8452-58275369

Area :

3 Acres (Owned)

 

 

DIRECTORS

 

Name :

Mr. U. Amarmata

Designation :

Director

Address :

36/A, Vengal Rao Nagar, Hyderabad – 500038

Date of Birth/Age :

17.04.1963

Qualification :

B. Pharma

Date of Appointment :

24.12.1992

 

 

Name :

Mr. V S N Murthy

Designation :

Director

Address :

36/A, Vengal Rao Nagar, Hyderabad – 500038

Date of Birth/Age :

23.03.1936

Qualification :

MSC

Date of Appointment :

28.08.1995

 

 

Name :

Mr. A V Ramakrishna Rao

Designation :

Director

Address :

Flat No. 1, Green Lands Towers, Ameerpet, Hyderabad – 500016, Andhra Pradesh, India

Date of Birth/Age :

02.08.1961

Date of Appointment :

28.08.1995

 

 

KEY EXECUTIVES

 

Name :

Mr. Mohan S Rao

Designation :

Secretary

Address :

B – 13, F – 1, P S Nagar, Vijayanagar Colony, Hyderabad – 500057, Andhra Pradesh, India

Tel No. :

91-40-23340985 / 23341213

Fax No.:

91-40-23398807

Email :

Dhr300@yahoo.com

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

Names of Shareholders

 

No. of Shares

Venkatarma Chemicals Limited

 

300

V S N Murthy

 

430

U Amarnath

 

290

M S Venkaranarayana

 

10

A V Ramakrishna Rao

 

240

B Ramakrishna Chowdary

 

120

N Satyanarayana

 

80

V Sira maha Lakshmi

 

80

U Vijaya

 

80

A Madhuri

 

80

N Lakshmi

 

80

Total

 

1790

 

 

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Bulk Drugs

 

 

Products :

  • Pheniramine Maleate
  • Impramine HCL
  • IMI Pramine HCL

 

 

Exports :

 

Countries :

Europe

 

 

Imports :

 

Countries :

Japan, Germany, China and Singapore

 

PRODUCTION STATUS

 

 

Unit

 

 

 

Licensed Capacity

Tonnes

35

 

 

Installed Capacity

Tonnes

35

 

 

 

 

GENERAL INFORMATION

 

No. of Employees :

23

 

 

Bankers :

State Bank of India

Balkampet Branch, 7-1-421, Swastik Plaza, S. R. Nagar, Hyderabad – 500038, Andhra Pradesh, India

 

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

B N and Company

Chartered Accountants

Address :

8-2-120/112/A/14 Road, No. 9, Jubilee Hills, Hyderabad – 500034, Andhra Pradesh, India

Tel. No.:

91-40-23706974

 

 

Associates/Subsidiaries :

Nil

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

5000

Equity Shares

Rs. 1000/- each

Rs. 5.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

1,790

Equity Shares

Rs. 1000/- each

Rs. 1.790 millions

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2007

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

1.790

1.790

1.790

2] Share Application Money

0.000

1.200

1.200

3] Reserves & Surplus

32.993

33.094

31.213

4] (Accumulated Losses)

[4.300]

0.000

0.000

NETWORTH

30.483

36.084

34.203

LOAN FUNDS

 

 

 

1] Secured Loans

89.802

14.360

9.775

2] Unsecured Loans

0.000

32.000

18.000

TOTAL BORROWING

89.802

46.360

27.775

DEFERRED TAX LIABILITIES

 

 

 

 

 

 

 

TOTAL

120.285

82.444

61.978

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

66.576

21.624

23.104

Capital work-in-progress

0.000

18.132

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

Inventories

 

17.669

12.866

 

Sundry Debtors

 

22.484

11.823

 

Cash & Bank Balances

80.824

0.019

0.002

 

Other Current Assets

 

14.215

16.219

 

Loans & Advances

 

2.994

3.632

Total Current Assets

80.824

57.381

44.542

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

27.115

14.693

5.668

 

Provisions

 

0.000

0.000

Total Current Liabilities

27.115

14.693

5.668

Net Current Assets

53.709

42.688

38.874

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

120.285

82.444

61.978

 

PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

 

31.03.2006

31.03.2005

 

 

 

 

Sales Turnover

 

82.814

68.343

Other Income

 

8.519

6.732

Total Income

 

91.333

75.075

 

 

 

 

Profit/(Loss) Before Tax

 

2.721

3.143

Provision for Taxation

 

0.840

0.959

Profit/(Loss) After Tax

 

1.881

2.184

 

 

 

 

Earnings in Foreign Currency :

 

 

 

Total Earnings

 

42.936

39.142

 

 

 

 

Expenditures :

 

 

 

 

Increase/(Decrease) in Finished Goods

 

2.951

1.850

 

Interest

 

4.987

4.004

 

Depreciation & Amortization

 

1.480

0.833

 

Other Expenditure

 

85.096

68.945

Total Expenditure

 

94.514

75.632

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2007

31.03.2006

31.03.2005

PAT / Total Income

(%)

NA

2.06

2.91

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

NA

3.29

4.60

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

NA

3.44

4.65

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

NA

0.08

0.09

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

3.84

1.69

0.98

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.98

3.91

7.86

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Bankers Charges Report as per Registry

 

Name of the company

HARIKA DRUGS PRIVATE LIMITED

Presented By

Managing Director 

1) Date and description of instrument creating the change

07.11.1997 agreement for the grant of small industrial advance

2) Amount secured by the charge/amount owing on the securities of charge

Rs. 1.500 Millions

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

Receivables and bill in the course of collections

4) Gist of the terms and conditions and extent and operation of the charge.

Interest @ 2.75 % over SBI advance rate with a minimum of 17.75 %

5) Name and Address and description of the person entitled to the charge.

State Bank of India, Balkampet Branch

6) Date  and brief description of instrument modifying the charge

--

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

--

 

 

Corporate identity number of the company

U24230AP1989PTC010584

Name of the company

HARIKA DRUGS PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

36/A, Vengal Rao Nagar, S. R. Nagar,  Hyderabad – 500038, Andhra Pradesh

This form is for

Modification of Charge

Type of charge

  • Hypothecation
  • Equitable mortgage or mortgage of property by deposition the title deeds

Particular of charge holder

State Bank of India

Balkampet Branch, 7-1-421, Swastik Plaza, S. R. Nagar, Hyderabad – 500038, Andhra Pradesh, India

ramuare@rdiffmail.com 

Amount secured by the charge

Rs. 58.500 Millions

Brief of the principal terms an conditions and extent and operation of the charge

ROI : CC – 11.75 %

TL : 12.25 ?%

Margin – Stock : 25 %

And Receivable 40 %

T. L. : 33.45 %

Term loan is repayable in 20 quarterly installments commencing from 01.02.2007 and the last installment falling due on 01.11.2011

Description of the property charged indicating whether it is a charged on

  • Immovable properties
  • Stock in trade
  • Plant and Machinery
  • Furniture and Fixture
  • Book debts
  • Vehicles

Charge identification number of the charge to be modified

80008296

Brief description of the instrument modifying the charge under section 135

Supplemental agreement of loan cum hypothecation dated 27.07.2006

Memorandum for recording extension of mortgage by deposit of title deeds covering enhanced limits and or creation 

Date of instrument modifying the charge

27.07.2006

Particulars of the present modification

The present limit is increased to Rs. 58.500 Millions from Rs. 12.000 Millions CC Rs. 20.000 Millions TL : Rs. 25.000 Millions and LC Rs. 13.500 Millions

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.39.40

UK Pound

1

Rs.81.12

Euro

1

Rs.56.69

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

46

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions